posted on 2012-04-12, 00:00authored byAdriano Mollica, Francesco Pinnen, Azzurra Stefanucci, Federica Feliciani, Cristina Campestre, Luisa Mannina, Anatoly P. Sobolev, Gino Lucente, Peg Davis, Josephine Lai, Shou-Wu Ma, Frank Porreca, Victor
J. Hruby
Endomorphin-2 (EM-2: Tyr-Pro-Phe-Phe-NH2)
is an endogenous
tetrapeptide that combines potency and efficacy with high affinity
and selectivity toward the μ opioid receptor, the most responsible
for analgesic effects in the central nervous system. The presence
of the Pro2 represents a crucial factor for the ligand
structural and conformational properties. Proline is in fact an efficient
stereochemical spacer, capable of inducing favorable spatial orientation
of aromatic rings, a key factor for ligand recognition and interaction
with receptors. Here the Pro2 has been replaced by 4(S)-NH2-2(S)-proline (cAmp),
a proline/GABA cis-chimera residue. This bivalent amino acid maintains
the capacity to influenc the tetrapeptide conformation and offers
the opportunity to generate new linear models and unusually constrained
cyclic analogues characterized by an N-terminal Tyr bearing a free
α-amino group. The results indicate that the new analogues do
not show affinity for both δ and κ opioid receptors and
bind only poorly to the μ receptors (for cyclopeptide 9: Kiμ = 660
nM; GPI (IC50) = 1.4% at 1 μM; for linear tetrapeptide
acid 13: Kiμ = 2000 nM; GPI (IC50) = 0% at 1 μM; for linear
tetrapeptide amide 15: Kiμ = 310 nM; GPI (IC50) = 894 nM).